Research Highlights: In a Phase 1, first-in-human trial, a one-time infusion of an investigational CRISPR-Cas9 therapy targeting angiopoietin-like protein 3 (ANGPTL3) was safe and reduced LDL cholesterol by nearly 50% and reduced triglycerides by...
  • surewhynotlem@lemmy.worldEnglish
    03·
    2 days ago

    I didn’t say to eat the cholesterol. Eating cholesterol isn’t the primary driver of blood cholesterol levels. Saturated fats are.